• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis.

作者信息

Taggart H, Cheng J, Archbold P

出版信息

Osteoporos Int. 2010 Sep;21(9):1621-2. doi: 10.1007/s00198-009-1088-6. Epub 2009 Oct 8.

DOI:10.1007/s00198-009-1088-6
PMID:19813042
Abstract
摘要

相似文献

1
Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis.静脉输注唑来膦酸治疗绝经后骨质疏松症相关的呼吸系统并发症。
Osteoporos Int. 2010 Sep;21(9):1621-2. doi: 10.1007/s00198-009-1088-6. Epub 2009 Oct 8.
2
Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.唑来膦酸：新适应症。对绝经后骨质疏松症无治疗优势。
Prescrire Int. 2008 Aug;17(96):143.
3
Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.静脉用双膦酸盐治疗绝经后骨质疏松症：唑来膦酸和伊班膦酸在临床实践中的安全性特征。
Clin Drug Investig. 2013 Feb;33(2):117-22. doi: 10.1007/s40261-012-0041-1.
4
Annual zoledronic acid for osteoporosis.用于治疗骨质疏松症的每年一次唑来膦酸
Drug Ther Bull. 2008 Dec;46(12):93-6.
5
Effect of zoledronic acid therapy on postmenopausal osteoporosis between the Uighur and Han population in Xinjiang: An open-label, long-term safety and efficacy study.唑来膦酸治疗对新疆维吾尔族和汉族绝经后骨质疏松症的影响：一项开放标签的长期安全性和疗效研究。
J Clin Pharm Ther. 2018 Jun;43(3):336-341. doi: 10.1111/jcpt.12647. Epub 2017 Nov 7.
6
Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.唑来膦酸5mg输注后中国绝经后骨质疏松症女性急性期反应观察的多中心研究
Orthop Surg. 2017 Aug;9(3):284-289. doi: 10.1111/os.12338.
7
Yearly zoledronic acid in postmenopausal osteoporosis.绝经后骨质疏松症的每年一次唑来膦酸治疗
N Engl J Med. 2007 Aug 16;357(7):713-4; author reply 714-5.
8
Osteonecrosis of the jaw.颌骨骨坏死
J Am Dent Assoc. 2008 Apr;139(4):398; author reply 398-400. doi: 10.14219/jada.archive.2008.0169.
9
A once-yearly IV bisphosphonate for osteoporosis.一种用于治疗骨质疏松症的每年静脉注射一次的双膦酸盐药物。
Med Lett Drugs Ther. 2007 Nov 5;49(1273):89-90.
10
Yearly zoledronic acid in postmenopausal osteoporosis.绝经后骨质疏松症的年度唑来膦酸治疗
N Engl J Med. 2007 Aug 16;357(7):711-2; author reply 714-5.

引用本文的文献

1
Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.血清Sema4D水平与绝经后骨质疏松症患者的腰椎骨密度及骨转换标志物相关。
Int J Clin Exp Med. 2015 Sep 15;8(9):16352-7. eCollection 2015.

本文引用的文献

1
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.每年一次唑来膦酸用于治疗绝经后骨质疏松症。
N Engl J Med. 2007 May 3;356(18):1809-22. doi: 10.1056/NEJMoa067312.
2
Fatal cholestatic jaundice in elderly patients taking benoxaprofen.服用苯恶洛芬的老年患者发生致命性胆汁淤积性黄疸。
Br Med J (Clin Res Ed). 1982 May 8;284(6326):1372. doi: 10.1136/bmj.284.6326.1372.